High ATLS scores correlate with poor prognosis, increased tumor mutations, immune activation, elevated T cell proliferation regulators, anti-PD-L1 response, and abnormal sensitivity to oxaliplatin/fluorouracil/Lenvatinib. The gene discussed is CD274; the disease is neoplasm.